Foghorn Therapeutics Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
FLAGSHIP PIONEERING INC. | 02/14/2025 | 12.67 M | $59.82 M | 0.00% | 20.25% |
FMR LLC | 02/13/2025 | 5.69 M | $26.86 M | -10.17% | 9.09% |
BVF INC/IL | 02/14/2025 | 5.30 M | $25.03 M | 0.00% | 8.47% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 02/14/2025 | 3.26 M | $15.37 M | 7.52% | 5.20% |
RAYMOND JAMES FINANCIAL INC | 02/13/2025 | 2.03 M | $9.58 M | 100.00% | 3.24% |
BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.03 M | $9.58 M | 12.03% | 3.24% |
VANGUARD GROUP INC | 02/11/2025 | 1.75 M | $8.26 M | 1.02% | 2.79% |
EUCLIDEAN CAPITAL LLC | 02/14/2025 | 1.57 M | $7.43 M | 0.00% | 2.51% |
SIREN, L.L.C. | 02/14/2025 | 720,720 | $3.40 M | 0.00% | 1.15% |
GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 682,863 | $3.22 M | 0.81% | 1.09% |
POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 634,761 | $3.00 M | 58.81% | 1.01% |
STATE STREET CORP | 02/14/2025 | 567,367 | $2.68 M | 12.14% | 0.91% |
ALPHABET INC. | 02/07/2025 | 500,901 | $2.36 M | 0.00% | 0.80% |
BIRCHVIEW CAPITAL, LP | 02/14/2025 | 310,930 | $1.47 M | -3.12% | 0.50% |
DAFNA CAPITAL MANAGEMENT LLC | 02/14/2025 | 186,717 | $881,304 | 395.74% | 0.30% |
SIO CAPITAL MANAGEMENT, LLC | 02/14/2025 | 121,672 | $574,292 | 0.00% | 0.19% |
ROCKWOOD WEALTH MANAGEMENT, LLC | 01/21/2025 | 107,329 | $494,787 | 0.00% | 0.17% |
D. E. SHAW & CO., INC. | 02/14/2025 | 100,367 | $473,732 | 44.01% | 0.16% |
MILLENNIUM MANAGEMENT LLC | 02/14/2025 | 92,640 | $437,261 | 58.81% | 0.15% |
WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 87,069 | $410,966 | 20.57% | 0.14% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 75,495 | $356,336 | 0.00% | 0.12% |
GOLDMAN SACHS GROUP INC | 02/11/2025 | 74,656 | $352,376 | 63.87% | 0.12% |
TREXQUANT INVESTMENT LP | 02/12/2025 | 61,598 | $290,743 | 1.64% | 0.10% |
NUVEEN ASSET MANAGEMENT, LLC | 02/14/2025 | 60,438 | $285,268 | 0.00% | 0.10% |
BANK OF NEW YORK MELLON CORP | 02/04/2025 | 58,312 | $275,232 | 3.49% | 0.09% |
JPMORGAN CHASE & CO | 02/12/2025 | 56,531 | $266,826 | 415.51% | 0.09% |
PANAGORA ASSET MANAGEMENT INC | 02/13/2025 | 55,154 | $260,327 | 40.55% | 0.09% |
BARCLAYS PLC | 02/13/2025 | 51,609 | $245,000 | 29.28% | 0.08% |
QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 49,643 | $234,315 | 141.58% | 0.08% |
RENAISSANCE TECHNOLOGIES LLC | 02/13/2025 | 47,736 | $225,314 | 89.16% | 0.08% |
BAKER BROS. ADVISORS LP | 02/14/2025 | 45,027 | $212,527 | 0.00% | 0.07% |
STATE OF WISCONSIN INVESTMENT BOARD | 02/14/2025 | 41,144 | $194,200 | 142.82% | 0.07% |
UBS GROUP AG | 02/14/2025 | 37,495 | $176,976 | 214.29% | 0.06% |
RHUMBLINE ADVISERS | 01/30/2025 | 36,384 | $171,721 | 9.15% | 0.06% |
ACADIAN ASSET MANAGEMENT LLC | 02/11/2025 | 35,784 | $168,000 | -15.54% | 0.06% |
CORTON CAPITAL INC. | 02/14/2025 | 34,576 | $163,199 | -34.89% | 0.06% |
WALLEYE CAPITAL LLC | 02/13/2025 | 34,048 | $160,707 | -24.21% | 0.05% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 02/14/2025 | 33,500 | $158,120 | -42.74% | 0.05% |
01/29/2025 | 28,471 | $134,383 | 100.00% | 0.05% | |
CITIGROUP INC | 02/12/2025 | 20,032 | $94,550 | 9.20% | 0.03% |
HSBC HOLDINGS PLC | 02/14/2025 | 18,728 | $88,209 | 12.37% | 0.03% |
EXCHANGE TRADED CONCEPTS, LLC | 01/21/2025 | 18,085 | $85,361 | 0.00% | 0.03% |
ALLIANCEBERNSTEIN L.P. | 02/12/2025 | 17,380 | $82,034 | 0.00% | 0.03% |
LOS ANGELES CAPITAL MANAGEMENT LLC | 02/04/2025 | 15,851 | $74,817 | 100.00% | 0.03% |
WELLS FARGO & COMPANY/MN | 02/13/2025 | 15,841 | $74,770 | 33.31% | 0.03% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 15,798 | $74,567 | -60.10% | 0.03% |
SHERBROOKE PARK ADVISERS LLC | 02/14/2025 | 15,617 | $73,712 | 22.24% | 0.02% |
ALTA WEALTH ADVISORS LLC | 01/23/2025 | 15,032 | $70,951 | 0.00% | 0.02% |
MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 02/14/2025 | 14,472 | $68,308 | 4.39% | 0.02% |
BNP PARIBAS ARBITRAGE, SNC | 02/14/2025 | 12,946 | $61,105 | 100.00% | 0.02% |
Foghorn Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 92 institutional investors and hedge funds held shares of Foghorn Therapeutics Inc.. The most heavily invested institutionals were:
Flagship Pioneering Inc.: 12.67 M
FMR LLC: 5.69 M
BVF INC/IL: 5.3 M
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C): 3.26 M
RAYMOND JAMES FINANCIAL INC: 2.03 M
BlackRock Funding, Inc. /DE: 2.03 M
64.28% of Foghorn Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 44.03 M shares in the last 24 months. This purchase volume represents approximately $205.17 M in transactions.